ScoreWhy is Haisco Pharmaceutical Group Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 7.87% and Operating profit at 23.27% over the last 5 years
2
With a growth in Net Profit of 1089.85%, the company declared Outstanding results in Mar 26
- OPERATING CASH FLOW(Y) Highest at CNY 1,126.55 MM
- ROCE(HY) Highest at 17.13%
- RAW MATERIAL COST(Y) Fallen by -19.75% (YoY)
3
With ROE of 15.84%, it has a very expensive valuation with a 5.14 Price to Book Value
- Over the past year, while the stock has generated a return of 24.53%, its profits have risen by 81.8% ; the PEG ratio of the company is 0.4
- At the current price, the company has a high dividend yield of 1.2
4
Consistent Returns over the last 3 years
- Along with generating 24.53% returns in the last 1 year, the stock has outperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Haisco Pharmaceutical Group Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Haisco Pharmaceutical Group Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Haisco Pharmaceutical Group Co., Ltd.
35.35%
1.65
45.65%
China Shanghai Composite
21.43%
1.55
13.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.87%
EBIT Growth (5y)
23.27%
EBIT to Interest (avg)
4.76
Debt to EBITDA (avg)
2.08
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
0.62
Tax Ratio
0.70%
Dividend Payout Ratio
115.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.05%
ROE (avg)
12.23%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
5.14
EV to EBIT
38.65
EV to EBITDA
28.96
EV to Capital Employed
4.92
EV to Sales
4.97
PEG Ratio
0.40
Dividend Yield
1.20%
ROCE (Latest)
12.72%
ROE (Latest)
15.84%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend39What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 1,126.55 MM
ROCE(HY)
Highest at 17.13%
RAW MATERIAL COST(Y)
Fallen by -19.75% (YoY
CASH AND EQV(HY)
Highest at CNY 3,326.59 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 6.12 %
DEBTORS TURNOVER RATIO(HY)
Highest at 4.88 times
NET SALES(Q)
Highest at CNY 1,563.99 MM
OPERATING PROFIT(Q)
Highest at CNY 553.39 MM
OPERATING PROFIT MARGIN(Q)
Highest at 35.38 %
PRE-TAX PROFIT(Q)
Highest at CNY 592.17 MM
NET PROFIT(Q)
Highest at CNY 554.61 MM
EPS(Q)
Highest at CNY 0.5
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Haisco Pharmaceutical Group Co., Ltd.
Pre-Tax Profit
At CNY 592.17 MM has Grown at 751.71%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 554.61 MM has Grown at 1,087.05%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Operating Cash Flow
Highest at CNY 1,126.55 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
At CNY 1,563.99 MM has Grown at 77.13%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (CNY MM)
Net Sales
Highest at CNY 1,563.99 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 553.39 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 35.38 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CNY 592.17 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 554.61 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.5
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Cash and Eqv
Highest at CNY 3,326.59 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 6.12 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 4.88 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -19.75% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
